文献速递临床试验与 GCP

目标导向液体治疗对头颈癌手术术后结局的影响:一项随机对照试验的研究方案

Effect of goal-directed fluid therapy on the postoperative outcome in head and neck cancer surgery: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2025-10-15

该研究为前瞻性、单中心、部分盲法随机对照试验,计划纳入340例成人头颈癌手术患者,随机分为目标导向液体治疗组(G组)和传统液体治疗组(C组)。G组采用每搏量变异度(SVV)≤12%且心脏指数(CI)最低控制在2.5 L/min/m²的目标导向液体治疗方案,C组依据平均动脉压(MAP)和尿量进行传统液体治疗。主要结局为术后30天内发生的严重术后并发症。

要点

  • 目标导向液体治疗组控制每搏量变异度(SVV)≤12%,心脏指数(CI)最低2.5 L/min/m²。
  • 传统液体治疗组依据平均动脉压(MAP)和尿量进行液体管理。
  • 主要结局为术后30天内严重术后并发症,计划纳入340例成人患者。

核心结论

  • 该研究旨在评估目标导向液体治疗能否减少头颈癌手术患者严重术后并发症的发生并缩短术后住院时间。
  • 研究结果将为头颈癌患者术中液体管理方法的选择提供证据。

研究设计与样本

  • 前瞻性、单中心、部分盲法随机对照试验,计划纳入340例择期行头颈癌手术的成人患者。
  • 两组均接受标准全身麻醉,随机分配至目标导向液体治疗组(G组)或传统液体治疗组(C组)。

主要发现

  • 原文未报告研究结果。

关键数值与推荐

  • G组采用与每搏量变异度(SVV)≤12%相关的目标导向液体治疗方案,且心脏指数(CI)最低控制在2.5 L/min/m²。
  • C组依据平均动脉压(MAP)和尿量进行传统液体治疗。
  • 主要结局为术后30天内发生的严重术后并发症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative complications have become the main cause of prolonged hospitalization and reduced postoperative survival rate among surgical patients. Goal-directed fluid therapy (GDFT) has been reported to reduce the incidence of postoperative complications and mortality, shorten the hospital stay, and improve the outcome in major abdominal surgery patients. However, the benefit of GDFT in patients undergoing head and neck cancer surgery remains controversial. The purpose of this study is to evaluate whether GDFT can reduce the occurrence of serious postoperative complications and shorten the postoperative hospital stay, compared with standard conventional fluid therapy in patients undergoing head and neck cancer surgery. METHODS: A total of 340 adult patients who scheduled for head and neck cancer surgery will be enrolled in this prospective, single-center, partly blinded, randomized controlled trial. Both groups will receive standard general anesthesia. Participants will be randomly assigned to GDFT group (group G) or conventional fluid therapy group (group C). Patients in group G will receive GDFT protocol associated with the stroke volume variation (SVV) ≤ 12% and the cardiac index (CI) was controlled at a minimum of 2.5 L/min/m2, whereas patients in group C underwent conventional fluid therapy based on mean arterial pressure (MAP) and urine output. The primary outcome is serious postoperative complications occurred within 30 days after surgery. DISCUSSION: This study will better demonstrate whether GDFT has a positive effect on postoperative outcomes in head and neck cancer patients. Results of the study will provide evidence for selecting appropriate intraoperative fluid management methods in such patients. TRIAL REGISTRATION: ClinicalTrials.gov NCT06468852. Registered on June 21, 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Liang X, Xi C, Zhou H, et al. Effect of goal-directed fluid therapy on the postoperative outcome in head and neck cancer surgery: study protocol for a randomized controlled trial. Trials. 2025. PMID: 41094585. doi:10.1186/s13063-025-09152-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。